Kazia Therapeutics Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 05/14/2026 | 400.00 K | $2.98 M | 0.00% | 12.82% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 345.18 K | $2.57 M | -25.02% | 11.06% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 200.00 K | $1.49 M | 0.00% | 6.41% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 193.11 K | $1.44 M | 100.00% | 6.19% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 05/05/2026 | 142.47 K | $1.06 M | 100.00% | 4.57% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 135.32 K | $1.01 M | -54.90% | 4.34% |
| DAUNTLESS INVESTMENT GROUP, LLC | 05/14/2026 | 79.83 K | $593.95 K | 7,983,100.00% | 2.56% |
| SEQUOIA FINANCIAL ADVISORS, LLC | 04/30/2026 | 60.00 K | $446.40 K | 100.00% | 1.92% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 05/04/2026 | 50.43 K | $375.16 K | 63.32% | 1.62% |
| ROYAL BANK OF CANADA | 05/15/2026 | 34.34 K | $255.00 K | -36.56% | 1.10% |
| BARCLAYS PLC | 05/15/2026 | 24.00 K | $178.55 K | 0.00% | 0.77% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 15.75 K | $117.17 K | 100.00% | 0.50% |
| UBS GROUP AG | 05/05/2026 | 13.93 K | $103.67 K | 7,119.69% | 0.45% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2026 | 12.70 K | $94.49 K | 18.69% | 0.41% |
| LAIRD NORTON TRUST COMPANY, LLC | 05/15/2026 | 12.40 K | $92.26 K | 100.00% | 0.40% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 10.61 K | $78.92 K | 100.00% | 0.34% |
| FNY INVESTMENT ADVISERS, LLC | 04/15/2026 | 10.00 K | $74.00 K | 33.33% | 0.32% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 8.74 K | $65.05 K | 87,340.00% | 0.28% |
| GAMMA INVESTING LLC | 04/06/2026 | 1.57 K | $11.67 K | 575.86% | 0.05% |
| RHUMBLINE ADVISERS | 05/12/2026 | 1.40 K | $10.43 K | -10.42% | 0.04% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 1.08 K | $8.04 K | 100.00% | 0.03% |
| MORGAN STANLEY | 05/15/2026 | 1.00 K | $7.44 K | 0.00% | 0.03% |
| ALLWORTH FINANCIAL LP | 05/15/2026 | 1 | $8 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| EMPERY ASSET MANAGEMENT, LP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kazia Therapeutics Limited institutional Ownership - FAQ's
During the previous two years, 30 institutional investors and hedge funds held shares of Kazia Therapeutics Limited. The most heavily invested institutionals were:
Bleichroeder LP: 400,000
Stonepine Capital Management, LLC: 345,179
Point72 Asset Management, L.P.: 200,000
BALYASNY ASSET MANAGEMENT L.P.: 193,114
FLPUTNAM INVESTMENT MANAGEMENT CO: 142,469
Velan Capital Investment Management LP: 135,315
56.21% of Kazia Therapeutics Limited stock is owned by institutional investors.
Institutional investors have bought a total of 1.75 M shares in the last 24 months. This purchase volume represents approximately $14.42 M in transactions.